MD Anderson in Sugar Land is a clinical research site located in Sugar Land, Texas, United States 77478.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
MD Anderson in Sugar Land has participated in 94 clinical trials with 76 currently active.
Therapeutic areas: Atypical Endometrial Hyperplasia, Stage I Uterine Corpus Cancer AJCC v7, Stage IA Uterine Corpus Cancer AJCC v7.
Sponsors: M.D. Anderson Cancer Center, SWOG Cancer Research Network, National Cancer Institute (NCI).
Trust Score: 87/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MD Anderson in Sugar Land has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MD Anderson in Sugar Land has 94 clinical trials on record, with 76 currently active. Their work covers Atypical Endometrial Hyperplasia, Stage I Uterine Corpus Cancer AJCC v7, Stage IA Uterine Corpus Cancer AJCC v7.
Yes — MD Anderson in Sugar Land holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.